{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:29:15Z","timestamp":1794324555736,"version":"4.9.0"},"reference-count":151,"publisher":"ScopeMed","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.scopemed.org\/?page=license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.5455\/medarh.2018.72.262-266","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T20:44:19Z","timestamp":1534797859000},"source":"Crossref","is-referenced-by-count":28,"title":["Effect of Long-term Carbamazepine Therapy on Bone Health"],"prefix":"10.5455","member":"3407","reference":[{"key":"ref1","unstructured":"1. Fisher RS, Cross JH, D\u2019Souza C. et al. Instruction manual for"},{"key":"ref2","unstructured":"the ILAE 2017 operational classification of seizure types. Ep -"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"ilepsia. 2017; 58(4): 531-542.","DOI":"10.1111\/jsap.12577"},{"key":"ref4","unstructured":"2. Mohanraj R, Brodie MJ. Pharmacologic outcomes in newly di -"},{"key":"ref5","unstructured":"Effect of Long-term Carbamazepine Therapy on Bone Health"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"265 ORIGINAL PAPER | MEd ARCH. 2018 AUG; 72(4): 262-266agnosed epilepsy. Epilepsy  Behav. 2005; 6(3): 382-387.","DOI":"10.1016\/j.yebeh.2005.01.008"},{"key":"ref7","unstructured":"3. Sander JW. The epidemiology of epilepsy revisited. Curr Opin"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Neurol. 2003;16(2): 165-170.","DOI":"10.1097\/00019052-200304000-00008"},{"key":"ref9","unstructured":"4. Miziak B, B\u0142aszczyk B, Chroscinska-Krawczyk M. et al. The"},{"key":"ref10","unstructured":"problem of osteoporosis in epileptic patients taking antie -"},{"key":"ref11","unstructured":"pileptic drugs. Expert Opin Drug Saf. 2014; 13(7): 935-946."},{"key":"ref12","unstructured":"5. Gallagher JC, Sai AJ. Vitamin D insufficiency, deficiency, and"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"bone health. J  Clin Endocrinol Metab. 2010; 95(6): 2630-2633.","DOI":"10.1210\/jc.2010-0918"},{"key":"ref14","unstructured":"6. Schuster I. Cytochromes P450 are essential players in the"},{"key":"ref15","unstructured":"vitamin D signaling system. Biochim Biophys Acta. 2011;"},{"key":"ref16","unstructured":"1814(1):186-199."},{"key":"ref17","unstructured":"7. Czuczwar S, Patsalos P. The new generation of GABA en-"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"hancers.CNS Drugs. 2001; 15(5): 339-350.","DOI":"10.2165\/00023210-200115050-00001"},{"key":"ref19","unstructured":"8. Meier C, Kraenzlin, ME. Antiepileptics and Bone Health. Ther"},{"key":"ref20","unstructured":"Adv Musculoskelet Dis. 2011; 3(5): 235-243."},{"key":"ref21","unstructured":"9. TolouGhamari Z. Antiepileptic Drugs (AEDs) Polypharmacy"},{"key":"ref22","unstructured":"could lead to buried pharmacokinetic interactions due to"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"CYP450. Drug Metab Lett. 2012; 6(3): 207-212.","DOI":"10.2174\/1872312811206030008"},{"key":"ref24","unstructured":"10. TolouGhamari Z, Najafi MR, Mehvari-Habibabadi J, Zare M."},{"key":"ref25","unstructured":"Preliminarily analysis of carbamazepine (CBZ) C0 in patients"},{"key":"ref26","unstructured":"visited Isfahan epileptic clinics. Int J Prev Med Suppl. 2013;"},{"key":"ref27","unstructured":"4(Suppl 2): S343-S346."},{"key":"ref28","unstructured":"11. TolouGhamari Z, Zare M, Mehvari-Habibabadi J, Najafi MR."},{"key":"ref29","unstructured":"Antiepileptic Drugs: A consideration of clinical and bio -"},{"key":"ref30","unstructured":"chemi-cal outcome in patients with epilepsy. Int J Prev Med"},{"key":"ref31","unstructured":"2013; 4 (Suppl 2): S330-337."},{"key":"ref32","unstructured":"12. Nettekoven S, Str\u00f6hle A, Trunz B, Wolters M, Hoffmann S,"},{"key":"ref33","unstructured":"Horn R, Steinert M, Brabant G, Lichtinghagen R, Welkob -"},{"key":"ref34","unstructured":"orsky HJ, Tuxhorn I, Hahn A. Effects of antiepileptic drug"},{"key":"ref35","unstructured":"therapy on vitamin D status and biochemical markers of bone"},{"key":"ref36","unstructured":"turnover in children with epilepsy. Eur J PediatrEur J. 2008;"},{"key":"ref37","unstructured":"167(12): 1369-1377."},{"key":"ref38","unstructured":"13. Verrotti A, Greco R, Morgese G, Chiarelli F. Increased bone"},{"key":"ref39","unstructured":"turnover in epileptic patients treated with carbamazepine."},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Ann Neurol. 2000; 47(3): 385-388.","DOI":"10.1002\/1531-8249(200003)47:3<385::AID-ANA18>3.3.CO;2-N"},{"key":"ref41","unstructured":"14. Samaniego EA, Sheth RD. Bone consequences of epilepsy"},{"key":"ref42","unstructured":"and antiepileptic medications. Semin Pediatr Neurol. 2007;"},{"key":"ref43","unstructured":"14(4): 196-200."},{"key":"ref44","unstructured":"15. Nissen-Meyer LS, Svalheim S, Taub\u00f8ll E, Gjerstad L, Reinholt"},{"key":"ref45","unstructured":"FP, Jemtland R. How can antiepileptic drugs affect bone mass,"},{"key":"ref46","unstructured":"structure and metabolism? Lessons from animal studies. Sei -"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"zure. 2008; 17(2): 187-191.","DOI":"10.1183\/09059180.00011003"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"16. Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;","DOI":"10.1016\/j.pbiomolbio.2006.02.016"},{"key":"ref49","unstructured":"92(1): 4-8."},{"key":"ref50","unstructured":"17. Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F. In -"},{"key":"ref51","unstructured":"creased bone turnover in prepubertal, pubertal, and post-pu -"},{"key":"ref52","unstructured":"bertal patients receiving carbamazepine. Epilepsia.2002;"},{"key":"ref53","unstructured":"43(12): 1488-1492."},{"key":"ref54","unstructured":"18. Andress DL, Ozuna J, Tirschwell D, Grande L, Johnson M, Ja -"},{"key":"ref55","unstructured":"cobson AF, Spain W. Antiepileptic drug-induced bone loss in"},{"key":"ref56","unstructured":"young male patients who have seizures. Arch Neurol. 2002;"},{"key":"ref57","unstructured":"59(5): 781-786."},{"key":"ref58","unstructured":"19. Pack AM, Morrell MJ, McMahon DJ, Shane E. Normal vi -"},{"key":"ref59","unstructured":"ta-min Dand low free estradiol levels in women on enzyme-in -"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"ducing antiepileptic drugs. Epilepsy  Behav. 2011; 21(4): 453-","DOI":"10.1016\/j.yebeh.2011.05.001"},{"key":"ref61","unstructured":"20. Feldkamp J, Becker A, Witte OW, et al. Long-term anticon -"},{"key":"ref62","unstructured":"vulsant therapy leads to low bone mineral density - evidence"},{"key":"ref63","unstructured":"for direct drug effects of phenytoin and carbamazepine on"},{"key":"ref64","unstructured":"human osteoblast - like cells. Exp Clin Endocrinol Diabetes. 2000; 108(1): 37-43."},{"key":"ref65","unstructured":"21. Fitzpatrick LA. Pathophysiology of bone loss in patients re -"},{"key":"ref66","unstructured":"ceiving anticonvulsant therapy. Epilepsy Behav. 2004; 5( Suppl"},{"key":"ref67","unstructured":"22. Lee R, Lyles K, Sloane R, Col\u00f3n-Emeric C. The association of"},{"key":"ref68","unstructured":"newer anticonvulsant medications and bone mineral density."},{"key":"ref69","unstructured":"Endocr Pract. 2012; 14: 1-22."},{"key":"ref70","unstructured":"23. Turan MI, Cayir A, Ozden O, Tan H. An Examination of the"},{"key":"ref71","unstructured":"Mutual Effects of Valproic Acid, Carbamazepine and Pheno -"},{"key":"ref72","unstructured":"barbital on 25-Hydroxyvitamin D Levels and Thyroid Func -"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"tion Tests. Neuropediatrics. 2014; 45(1): 16-21.","DOI":"10.1055\/s-0034-1390175"},{"key":"ref74","unstructured":"24. Wang Z, Lin YS, Dickmann LJ, Poulton EJ, Eaton DL.et al. En -"},{"key":"ref75","unstructured":"hancement of hepatic 4-hydroxylation of 25-hydroxyvita-min"},{"key":"ref76","unstructured":"D3 through CYP3A4 induction in vitro and in vivo: implica -"},{"key":"ref77","unstructured":"tions for drug-induced osteomalacia. J Bone Miner Res. 2013;"},{"key":"ref78","unstructured":"28(5): 1101-1116."},{"key":"ref79","unstructured":"25. Kir HM, Garip S, Sahin D, \u00d6zta\u015f B. Effects of carbamazepine"},{"key":"ref80","unstructured":"on serum parathormone, 25- hydroxyvitamin D, bone specific"},{"key":"ref81","unstructured":"alkaline phosphatase, C-telopeptide, and osteocalcin levels"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"in healthy rats. Bosn J Basic Med Sci. 2012; 12(4) : 240-244.","DOI":"10.17305\/bjbms.2012.2445"},{"key":"ref83","unstructured":"26. Brodie MJ, Mintzer S, Pack AM, Gidal BE, Vecht CJ, Schmidt"},{"key":"ref84","unstructured":"D. Enzyme induction with antiepileptic drugs: cause for con -"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"cern? Epilepsia. 2013; 54(1): 11-27.","DOI":"10.1111\/epi.12420"},{"key":"ref86","unstructured":"27. Aksoy A, S\u00f6nmez FM, Deger O, Hosver I, Karag\u00fczel G. The"},{"key":"ref87","unstructured":"effects of antiepileptic drugs on the relationships between"},{"key":"ref88","unstructured":"leptin levels and bone turnover in prepubertal children with"},{"key":"ref89","unstructured":"epilepsy. J Pediatr Endocrinol Metab. 2011; 24(9-10) : 703-708."},{"key":"ref90","unstructured":"28. Lee RH, Lyles KW, Colon-Emeric C. A Review of the Effect of"},{"key":"ref91","unstructured":"Anticonvulsant Medications on Bone Mineral Density and"},{"key":"ref92","unstructured":"Fracture  Risk.Am J Geriatr Pharmacother. 2010; 8(1): 34-46."},{"key":"ref93","unstructured":"29. Misra A, Aggarwal A, Singh O, Sharma S. Effect carbamaze -"},{"key":"ref94","unstructured":"pine therapy on vitamin D and parathormonein epileptic chil -"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"dren. Pediatr Neurol. 2010; 43(5): 320-324.","DOI":"10.1016\/j.pediatrneurol.2010.05.013"},{"key":"ref96","unstructured":"30. Nakken KO, Taub\u00f8ll E. Bone loss associated with use of an -"},{"key":"ref97","unstructured":"tiepileptic drugs. Expert Opin Drug Saf. 2010; 9(4): 561-571."},{"key":"ref98","unstructured":"31. Pack AM, Morrell MJ, Marcus R, et al. Bone mass and turn-"},{"key":"ref99","unstructured":"over in women with epilepsy on antiepileptic drug monother -"},{"key":"ref100","unstructured":"apy. Ann Neurol. 2005; 57(2): 252-257."},{"key":"ref101","unstructured":"32. Tjellesen L, Nilas L, Christiansen C. Does carbamazepine"},{"key":"ref102","unstructured":"cause disturbances in calcium metabolism in epileptic pa -"},{"key":"ref103","unstructured":"tients? Acta Neurol Scand. 1983; 68(1): 13-19."},{"key":"ref104","unstructured":"33. Shimada T, Yamazaki H, Mimura M, et al. Inter individual"},{"key":"ref105","unstructured":"variations in human liver cytochrome P450 enzymes involved"},{"key":"ref106","unstructured":"in the oxidation of drugs, carcinogens and toxic chemicals:"},{"key":"ref107","unstructured":"studies with liver microsomes of 30 Japanese and 30 Cauca -"},{"key":"ref108","doi-asserted-by":"crossref","unstructured":"sians. J  Pharmacol ExpTher. 1994; 270(1): 414-423.","DOI":"10.1016\/S0022-3565(25)22379-5"},{"key":"ref109","unstructured":"34. Guengerich FP, Turvy CG. Comparison of levels of human mi -"},{"key":"ref110","unstructured":"crosomal cytochrome P450 enzymes and epoxide hydrolase"},{"key":"ref111","unstructured":"in normal and disease states using immunochemical analy -"},{"key":"ref112","unstructured":"sis of surgical samples. J Pharmacol Exp Ther. 1991; 256(3):"},{"key":"ref113","unstructured":"35. Lambrinoudaki I, Kaparos G, Armeni E, Alexandrou A, Dam -"},{"key":"ref114","unstructured":"asko C. et al. BsmI vitamin D receptor\u2019s polymorphism and"},{"key":"ref115","unstructured":"bone mineral density in men and premenopausal women on"},{"key":"ref116","unstructured":"long-term antiepileptic therapy. Eur J Neurol. 2011; 18(1):"},{"key":"ref117","unstructured":"36. Zhou C, Assem M, Tay JC, Watkins PB, Blumberg B. et al. Ste -"},{"key":"ref118","unstructured":"roid and xenobiotic receptor and vitamin D receptor crosstalk"},{"key":"ref119","unstructured":"mediates CYP24 expression and drug-induced osteomalacia."},{"key":"ref120","doi-asserted-by":"crossref","unstructured":"J Clin Invest. 2006 ; 116(6): 1703-1712.","DOI":"10.1172\/JCI27793"},{"key":"ref121","unstructured":"Effect of Long-term Carbamazepine Therapy on Bone Health"},{"key":"ref122","unstructured":"266 ORIGINAL PAPER | MEd ARCH. 2018 AUG; 72(4): 262-26637. Heo K, Rhee Y, Lee HW, Lee SA, Shin DJ, et al. The effect of to"},{"key":"ref123","unstructured":"piramate monotherapy on bone mineral density and markers"},{"key":"ref124","unstructured":"of bone and mineral metabolism in premenopausal women"},{"key":"ref125","doi-asserted-by":"crossref","unstructured":"with epilepsy. Epilepsia. 2011; 52(10): 1884-1889.","DOI":"10.1111\/j.1528-1167.2011.03131.x"},{"key":"ref126","unstructured":"38. Pack AM. Treatment of epilepsy to optimize bone health. Curr"},{"key":"ref127","doi-asserted-by":"crossref","unstructured":"Treat Options Neurol. 2011; 13(4): 346-354.","DOI":"10.1007\/s11940-011-0133-x"},{"key":"ref128","unstructured":"39. Salimipour H, Kazerooni S, Seyedabadi M, Nabipour I, Nem -"},{"key":"ref129","unstructured":"ati R, Iranpour D, et al. Antiepileptic treatment is associated"},{"key":"ref130","unstructured":"with bone loss: Difference in drug type and region of interest."},{"key":"ref131","doi-asserted-by":"crossref","unstructured":"J Nucl Med Technol. 2013; 41(3): 208-211.","DOI":"10.1016\/j.mpmed.2013.01.018"},{"key":"ref132","unstructured":"40. Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-"},{"key":"ref133","unstructured":"Hajj Fuleihan G. Effect of antiepileptic drugs on bone density"},{"key":"ref134","doi-asserted-by":"crossref","unstructured":"in ambulatory patients. Neurology 2002; 58(9): 1348-1353.","DOI":"10.1212\/WNL.58.9.1348"},{"key":"ref135","unstructured":"41. Babayigit A, Dirik E, Bober E, Cakmakci H. Adverse effects"},{"key":"ref136","unstructured":"of antiepileptic drugs on bone mineral density. Pediatr Neu -"},{"key":"ref137","unstructured":"rol. 2006; 35(3): 177-181.42. Beerhorst K, Tan IY, De Krom M, Verschuure P, Aldenkamp"},{"key":"ref138","unstructured":"AP. Antiepileptic drugs and high prevalence of low bone min -"},{"key":"ref139","unstructured":"eral density in a group of inpatients with chronic epilepsy. Acta"},{"key":"ref140","doi-asserted-by":"crossref","unstructured":"Neurol Scand. 2013; 128(4): 273-280.","DOI":"10.1111\/ane.12118"},{"key":"ref141","unstructured":"43. Lado F, Spiegel R, Masur JH, Boro A and Haut SR. Value of"},{"key":"ref142","unstructured":"Routine Screening for Bone Demineralization in an Urban"},{"key":"ref143","unstructured":"Population of Patients with Epilepsy. Epilepsy Research. 2008;"},{"key":"ref144","unstructured":"78(2-3): 155-160."},{"key":"ref145","unstructured":"44. Pack AM, Olarte LS, Morrell MJ, Flaster E, Resor SR, Shane"},{"key":"ref146","unstructured":"E. Bone mineral density in an outpatient population receiv -"},{"key":"ref147","unstructured":"ing enzyme-inducing antiepileptic drugs. Epilepsy Behav."},{"key":"ref148","unstructured":"2003; 4(2): 169-174."},{"key":"ref149","unstructured":"45. Fuleihan GEH, Dib L, Yamout B, Sawaya R, Mikati MA. Pre -"},{"key":"ref150","unstructured":"dictors of bone density in ambulatory patients on antiepilep -"},{"key":"ref151","doi-asserted-by":"crossref","unstructured":"tic drugs. Bone. 2008; 43(1): 149-155.","DOI":"10.1016\/j.bone.2008.03.002"}],"container-title":["Medical Archives"],"original-title":[],"link":[{"URL":"https:\/\/ejmanager.com\/mnstemps\/10\/10-1534539907.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:55:56Z","timestamp":1791482156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejmanager.com\/mnstemps\/10\/10-1534539907.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":151,"URL":"https:\/\/doi.org\/10.5455\/medarh.2018.72.262-266","relation":{},"ISSN":["0350-199X"],"issn-type":[{"value":"0350-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}